Skip to main content
FDA OKs full-body MRI use in Axonics' SNM device trial

The FDA has granted Axonics Modulation Technologies approval for full-body MRI use for the 129 participants of a pivotal trial of its sacral neuromodulation device. The trial is designed to evaluate use of the device in treating overactive bladder.

Full Story: